Published on
September 30, 2026
- 18:49 GMT
VizMark Inc. Appoints Chris L. Marsh to Board of Directors
Veteran CEO, technology executive and investor joins the company behind VM-1, the first FDA-cleared non-metallic breast biopsy marker. MINNEAPOLIS, MN, UNITED STATES, September 30, 2026 /EINPresswire.com/ -- VizMark Inc., a Minnesota-based medical …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...